Patient Guide: A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 170 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT07076199
Status: NOT_YET_RECRUITING
Condition: Diabetes Mellitus, Type 1
Phase: PHASE3

Where You Can Participate

This study is available at 170 locations across the country.

Top locations include:
  • • Cullman, Alabama
  • • Concord, California
  • • Escondido, California
  • • And 167 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes - Join Clinical Trial NCTNCT07076199

How to Join This Clinical Trial - NCTNCT07076199

Learn how to participate in this PHASE3 trial studying an investigational therapy for Diabetes Mellitus, Type 1. Current status: NOT_YET_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Diabetes Mellitus, Type 1. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Diabetes Mellitus, Type 1
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
NOT_YET_RECRUITING
Study Identifier
NCTNCT07076199 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 170 locations. Find a study site near you:

Clinical Research Site

Cullman, Alabama 35055 - United States

Status: Contact for availability

Clinical Research Site

Concord, California 94520 - United States

Status: Contact for availability

Clinical Research Site

Escondido, California 92025 - United States

Status: Contact for availability

Clinical Research Site

Fresno, California 93704 - United States

Status: Contact for availability

Clinical Research Site

Fullerton, California 92835 - United States

Status: Contact for availability

Clinical Research Site

La Jolla, California 92037 - United States

Status: Contact for availability

Clinical Research Site

Loma Linda, California 92354 - United States

Status: Contact for availability

Clinical Research Site

Los Alamitos, California 90720 - United States

Status: Contact for availability

Clinical Research Site

Pasadena, California 91101 - United States

Status: Contact for availability

Clinical Research Site

Pomona, California 91766 - United States

Status: Contact for availability

And 160 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Diabetes Mellitus, Type 1:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships